1. Home
  2. PLSE vs MAX Comparison

PLSE vs MAX Comparison

Compare PLSE & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • MAX
  • Stock Information
  • Founded
  • PLSE 2014
  • MAX 2014
  • Country
  • PLSE United States
  • MAX United States
  • Employees
  • PLSE N/A
  • MAX N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • MAX Industrial Machinery/Components
  • Sector
  • PLSE Health Care
  • MAX Industrials
  • Exchange
  • PLSE Nasdaq
  • MAX Nasdaq
  • Market Cap
  • PLSE 1.1B
  • MAX 613.7M
  • IPO Year
  • PLSE 2016
  • MAX 2020
  • Fundamental
  • Price
  • PLSE $17.79
  • MAX $11.41
  • Analyst Decision
  • PLSE
  • MAX Buy
  • Analyst Count
  • PLSE 0
  • MAX 8
  • Target Price
  • PLSE N/A
  • MAX $24.25
  • AVG Volume (30 Days)
  • PLSE 168.8K
  • MAX 606.3K
  • Earning Date
  • PLSE 10-30-2024
  • MAX 02-18-2025
  • Dividend Yield
  • PLSE N/A
  • MAX N/A
  • EPS Growth
  • PLSE N/A
  • MAX N/A
  • EPS
  • PLSE N/A
  • MAX 0.19
  • Revenue
  • PLSE N/A
  • MAX $681,230,000.00
  • Revenue This Year
  • PLSE N/A
  • MAX $124.41
  • Revenue Next Year
  • PLSE N/A
  • MAX $31.11
  • P/E Ratio
  • PLSE N/A
  • MAX $59.80
  • Revenue Growth
  • PLSE N/A
  • MAX 72.47
  • 52 Week Low
  • PLSE $6.60
  • MAX $10.21
  • 52 Week High
  • PLSE $22.69
  • MAX $25.78
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 48.18
  • MAX 45.34
  • Support Level
  • PLSE $16.97
  • MAX $10.86
  • Resistance Level
  • PLSE $18.48
  • MAX $11.46
  • Average True Range (ATR)
  • PLSE 1.30
  • MAX 0.55
  • MACD
  • PLSE -0.10
  • MAX 0.17
  • Stochastic Oscillator
  • PLSE 27.68
  • MAX 61.11

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: